Infinity Pharmaceuticals Inc INFI Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125

20:30 EDT 15 Aug 2019 | BioPortfolio Reports

Infinity Pharmaceuticals Inc INFI Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Infinity Pharmaceuticals Inc Infinity Pharmaceuticals is a biopharmaceutical company that discovers and develops small molecule therapeutics for the treatment of cancer. The company's pipeline candidate: IPI549 selectively inhibits PI3Kgamma to reprogram tumorassociated macrophages and transforms immunooncology approach. It is evaluating IPI549 as a monotherapy in Phase 2 clinical trials for the treatment of a wide range of solid tumors. Infinity Pharmaceuticals is also investigating IPI549 in Phase 1 clinical studies for the treatment of advanced solid tumors, and in a combination therapy in Phase 1n clinical trials for the treatment of nonsmall cell lung cancer NSCLC, melanoma, squamous cell carcinoma of the head and neck SCCHN, triple negative breast cancer TNBC, mesothelioma, adrenocortical carcinoma, and myeloidderived suppressor cells MDSC. Infinity Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US.

Infinity Pharmaceuticals Inc Key Recent Developments

Mar 14,2019 Infinity Pharmaceuticals reports full year 2018 financial results and provides company update

Nov 07,2018 BristolMyers and Infinity partner for trial of opdivo and IPI549

Nov 05,2018 Infinity Pharmaceuticals announces third quarter 2018 financial results

Aug 07,2018 Infinity Pharmaceuticals provides company update and second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Infinity Pharmaceuticals Inc INFI Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125


More From BioPortfolio on "Infinity Pharmaceuticals Inc INFI Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...